News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

MiraiBio, Inc. Launches DNASIS MAX Version 2.5 Sequence Analysis Software For Advanced Data Management

10/19/2005 5:10:38 PM

BOSTON, March 31 /PRNewswire/ -- At the BioIT World Conference & Expo, MiraiBio Inc., today introduced DNASIS(R) MAX Version 2.5 Sequence Analysis Software, their next generation desktop bioinformatics tool offering advanced data management and analysis capabilities.

DNASIS(R) MAX is a robust sequence analysis software package that delivers industry standard functionality -- molecular biology tools, multiple consensus calling methods, and rapid BLAST searches -- as well as unique features that enhance common task performance and allow user-defined product customization.

"With the release of DNASIS(R) MAX Version 2.5, MiraiBio is doing what it does best -- taking advantage of its core competencies in computer technology and software design to deliver a sophisticated and powerful bioinformatics tool to researchers all over the world," commented Masakazu Kuji, Chief Executive Officer. "We are particularly pleased with the refinement of user- customization and overall research-facilitation features that are so prominently evident in this new version."

Notable functionality additions to DNASIS MAX Version 2.5 include customizable analyses and workflows using the product's unique open application programming interface (API) and software developer's kit (SDK) and direct interface with DNASIS Gene Index, the company's data query and knowledge mining service. Additional improved and enhanced product features include drag and drop analysis with instructional "wizard," improved tandem repeat, hairpin loop, tacking site search capabilities, and increased database functionality with novel text searching and editing options.

About MiraiBio:

MiraiBio is the culmination of 12 years of imaging, spectroscopy and microarray experience in the life science industry. Providing innovatively integrated system solutions, MiraiBio enables Genomic and Proteomic research in drug discovery, basic research, and forensics. Closely working with life science researchers and technicians, the company's core mission is to deliver solutions that do far more than follow technology trends; that put tomorrow's research tools into the laboratory today. Please visit our Web site at:

Media Contact: MiraiBio 510-337-2005 Tateo Nagai Title: Manager Bioinformatics Email:

MiraiBio Inc.

CONTACT: Tateo Nagai, Manager Bioinformatics of MiraiBio,+1-510-337-2005, or

Read at

comments powered by Disqus